Literature DB >> 28161983

Prospective correlates of early (30 day) readmissions on a Cardiothoracic Surgery Service.

Mark W Ketterer1, Mansi Chawa2, Gaetano Paone3.   

Abstract

Known to vary widely among hospitals for unclear reasons, early readmissions are associated with higher mortality and are suspected to frequently be due to inadequate discharge preparation/planning. It has been previously documented that the strongest and most consistent predictor of early readmissions in CHF patients is chronic cognitive impairment, and compensatory assistance with adherence on discharge improves early readmission rates. Prospective observational study. The present investigation examined multiple putative perioperative predictors of early readmission in a hospitalized Cardiothoracic Surgery Service. A subtest of the Mini-Cog, Short Term Memory, was the strongestunivariate predictor of early readmissions (p < .001), but the overall Mini-Cog (p = .024), Age (p = .045), Number of Admissions over the Preceding Year (p = .036), an Anxiety Scale (p = .035), Years of Education (p = .055) and a Depression Scale (p = .056) also demonstrated covariation. In a Logistic Regression, only Short Term Memory survived as a predictor variable (p = .007), correctly classifying 76% of patients. Chronic cognitive impairment is a predictor of early readmissions in Cardiothoracic patients. A brief bedside exam interpreted in medical context may permit identification of patients requiring familial assistance for adherence on discharge.

Entities:  

Keywords:  Readmissions; cardiothoracic; cognitive impairment; surgery; utilization; vascular

Mesh:

Year:  2017        PMID: 28161983     DOI: 10.1080/13548506.2017.1287408

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  1 in total

1.  The association of cognitive impairment as screened by the Mini-Cog with long term post-hospitalization outcomes.

Authors:  Ali Shami; Maura Brennan; Peter St Marie; Peter K Lindenauer; Mihaela S Stefan
Journal:  Arch Gerontol Geriatr       Date:  2019-07-18       Impact factor: 3.250

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.